Keywords: launch, glaxo, serevent, launched, its, long-acting, bronchodilator

US LAUNCH FOR GLAXO'S SEREVENT

Article | 11 April 1994

Print This

Glaxo has launched its long-acting bronchodilator product Serevent (salmeterol xinafoate) in the USA. The drug was approved by the Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in